Synthesis and biological evaluation of paclitaxel conjugates with prostate-specific membrane antigen inhibitor for the treatment of prostate cancer . .
https://doi.org/10.17650/1726-9784-2018-17-2-93
About the Authors
A. P. Ber
МГУ им. М.В. Ломоносова
Russian Federation
Russian Federation
A. E. Machulkin
МГУ им. М.В. Ломоносова
Russian Federation
Russian Federation
M. V. Kovalchuk
МГУ им. М.В. Ломоносова
Russian Federation
Russian Federation
N. S. Vorobyova
МГУ им. М.В. Ломоносова
Russian Federation
Russian Federation
E. K. Beloglazkina
МГУ им. М.В. Ломоносова
Russian Federation
Russian Federation
S. V. Kovalev
МГУ им. М.В. Ломоносова
Russian Federation
Russian Federation
V. E. Kotelyanskiy
МГУ им. М.В. Ломоносова
Russian Federation
Russian Federation
A. G. Mazhuga
МГУ им. М.В. Ломоносова
Russian Federation
Russian Federation
Review
For citations:
Ber A.P., Machulkin A.E., Kovalchuk M.V., Vorobyova N.S., Beloglazkina E.K., Kovalev S.V., Kotelyanskiy V.E., Mazhuga A.G. Synthesis and biological evaluation of paclitaxel conjugates with prostate-specific membrane antigen inhibitor for the treatment of prostate cancer . . Russian Journal of Biotherapy. 2018;17(2):93. (In Russ.) https://doi.org/10.17650/1726-9784-2018-17-2-93
Views:
359
Email this article 
